Ciprofloxacin Tablet, Film Coated
NDC Package 72789-511-14
Package Information
Ciprofloxacin (ciprofloxacin hydrochloride) tablets is a medication used to treat a variety of bacterial infections. This formulation utilizes a tablet, film coated delivery system. Marketed by Pd-rx Pharmaceuticals, Inc., this product is identified by NDC 72789-511 and is authorized under FDA application ANDA077859.
Identification & Billing
- RxCUI: 309309 - ciprofloxacin 500 MG Oral Tablet
- RxCUI: 309309 - ciprofloxacin (as ciprofloxacin HCl) 500 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72789 - Pd-rx Pharmaceuticals, Inc.
- 72789-511 - Ciprofloxacin
- 72789-511-14 - 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
- 72789-511 - Ciprofloxacin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72789-511). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72789-511-14 identifies a specific commercial package of 14 tablet, film coated in 1 bottle, plastic of Ciprofloxacin, a human prescription drug labeled by Pd-rx Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 14 billable units per package. This tablet, film coated is formulated for oral use and contains ciprofloxacin hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pd-rx Pharmaceuticals, Inc. on February 09, 2024.
What are the primary indications for this medication?
This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Pd-rx Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72789051114. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 14 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.